477 related articles for article (PubMed ID: 35745875)
1. Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches.
Navarro C; Ortega Á; Santeliz R; Garrido B; Chacín M; Galban N; Vera I; De Sanctis JB; Bermúdez V
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745875
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
Yoshida GJ
J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
[TBL] [Abstract][Full Text] [Related]
3. The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy.
Hoerner CR; Chen VJ; Fan AC
Kidney Cancer; 2019 Feb; 3(1):15-29. PubMed ID: 30854496
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming in cancer: Mechanisms and therapeutics.
Nong S; Han X; Xiang Y; Qian Y; Wei Y; Zhang T; Tian K; Shen K; Yang J; Ma X
MedComm (2020); 2023 Apr; 4(2):e218. PubMed ID: 36994237
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic regulation of tumor metabolic reprogramming.
Tarrado-Castellarnau M; de Atauri P; Cascante M
Oncotarget; 2016 Sep; 7(38):62726-62753. PubMed ID: 28040803
[TBL] [Abstract][Full Text] [Related]
6. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.
Magaway C; Kim E; Jacinto E
Cells; 2019 Dec; 8(12):. PubMed ID: 31817676
[TBL] [Abstract][Full Text] [Related]
7. Alone and together: current approaches to targeting glutaminase enzymes as part of anti-cancer therapies.
Nguyen TT; Katt WP; Cerione RA
Future Drug Discov; 2023 Mar; 4(4):FDD79. PubMed ID: 37009252
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
Tyszka-Czochara M; Konieczny P; Majka M
J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
[TBL] [Abstract][Full Text] [Related]
9. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.
Jin HR; Wang J; Wang ZJ; Xi MJ; Xia BH; Deng K; Yang JL
J Hematol Oncol; 2023 Sep; 16(1):103. PubMed ID: 37700339
[TBL] [Abstract][Full Text] [Related]
10. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
Huang L; Xu H; Peng G
Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
Nenkov M; Ma Y; Gaßler N; Chen Y
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Reprogramming in Tumor Immune Microenvironment: Impact on Immune Cell Function and Therapeutic Implications.
Liu Y; Zhao Y; Song H; Li Y; Liu Z; Ye Z; Zhao J; Wu Y; Tang J; Yao M
Cancer Lett; 2024 Jun; ():217076. PubMed ID: 38906524
[TBL] [Abstract][Full Text] [Related]
13. The Metabolic Landscape of Breast Cancer and Its Therapeutic Implications.
Jiao Z; Pan Y; Chen F
Mol Diagn Ther; 2023 May; 27(3):349-369. PubMed ID: 36991275
[TBL] [Abstract][Full Text] [Related]
14. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.
Li Z; Sun C; Qin Z
Theranostics; 2021; 11(17):8322-8336. PubMed ID: 34373744
[TBL] [Abstract][Full Text] [Related]
15. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.
Lian X; Yang K; Li R; Li M; Zuo J; Zheng B; Wang W; Wang P; Zhou S
Mol Cancer; 2022 Jan; 21(1):27. PubMed ID: 35062950
[TBL] [Abstract][Full Text] [Related]
16. Cancer metabolism and carcinogenesis.
Yang J; Shay C; Saba NF; Teng Y
Exp Hematol Oncol; 2024 Jan; 13(1):10. PubMed ID: 38287402
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Reprogramming of Cancer by Chemicals that Target Glutaminase Isoenzymes.
Matés JM; Campos-Sandoval JA; de Los Santos-Jiménez J; Segura JA; Alonso FJ; Márquez J
Curr Med Chem; 2020; 27(32):5317-5339. PubMed ID: 31038055
[TBL] [Abstract][Full Text] [Related]
18. The Neglected Liaison: Targeting Cancer Cell Metabolic Reprogramming Modifies the Composition of Non-Malignant Populations of the Tumor Microenvironment.
Iorio M; Umesh Ganesh N; De Luise M; Porcelli AM; Gasparre G; Kurelac I
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771610
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives.
Yu Z; Zhou X; Wang X
Cancer Res; 2022 Sep; 82(17):2955-2963. PubMed ID: 35771627
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis.
Ohshima K; Morii E
Metabolites; 2021 Jan; 11(1):. PubMed ID: 33401771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
